|
|
Article: Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction.(Clinical report)
- Article from:
- Alternative Medicine Review
- Article date:
- December 1, 2007
- Author:
CopyrightCOPYRIGHT 2007 Thorne Research Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Myo-inositol in patients with polycystic ovary syndrome: a novel method for ovulation induction. Papaleo E, Unfer V, Baillargeon JP, et al. Gynecol Endocrinol 2007 Oct 10:1-4 [Epub ahead of print]
Background. Polycystic ovary syndrome (PCOS) is often characterized by chronic oligo- or anovulation (usually manifested as oligo- or amenorrhea), and hyperandrogenism. In addition, 30-40% of PCOS women have impaired glucose tolerance, and a defect in the insulin signaling pathway (inositol-containing phosphoglycan mediators) seems to be implicated in the pathogenesis of insulin resistance. PCOS patients are subfertile as a consequence of such ovulatory disorders and ...
Related newspaper, magazine, and journal articles:
|
|
Article: Ovulation induction treatment and risk of ...
Gynecological Endocrinology;
July 1, 2007 ;
700+ words
... ... an association between the use of ovulation induction drugs and the risk of ovarian cancer ... relationship between the use of ovulation induction drugs and the appearance of borderline ... series produced no evidence that ovulation induction treatment predisposes women to the ...
|
|